PTPN11 and neoplasm: In PTEN-null senescent tumors, there is a downregulation of SHP2 and activation of JAK/STAT3 pathway, which contributes to the establishment of an immunosuppressive tumor microenvironment that promotes chemoresistance (Toso et al., 2014).